Akebia Therapeutics to Present at Upcoming February Investor Conferences
February 08 2018 - 08:00AM
Business Wire
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical
company focused on delivering innovative therapies to patients with
kidney disease through the biology of hypoxia-inducible factor
(HIF), today announced that John P. Butler, President and Chief
Executive Officer, will present at the following investor
conferences:
- the BIO CEO & Investor Conference
on Monday, February 12, 2018, at 2:15 p.m. Eastern Time, at the New
York Marriott Marquis in New York, NY; and
- the RBC Capital Markets 2018 Global
Healthcare Conference on Thursday, February 22, 2018, at 8:00 a.m.
Eastern Time at the Lotte New York Palace in New York, NY.
A live webcast of the presentations will be available on the
company’s website at www.akebia.com. To access the webcast, please
log onto the Akebia website at least 15 minutes prior to the
webcast to ensure adequate time for any software downloads that may
be required. A replay of the webcasts will be available on Akebia’s
website following the conferences.
About Akebia TherapeuticsAkebia Therapeutics,
Inc. is a biopharmaceutical company headquartered
in Cambridge, Massachusetts, focused on delivering innovative
therapies to patients with kidney disease through hypoxia-inducible
factor biology. For more information, please visit our website
at www.akebia.com, which does not form a part of this
release.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180208005168/en/
Akebia TherapeuticsJohn Garabo, 617-844-6130Director,
Corporate Communicationsjgarabo@akebia.com
Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Mar 2023 to Mar 2024